Schwartz Jeffrey Lawrence

SEC Form 4 insider trading activity

Schwartz Jeffrey Lawrence has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.

On the most recent filing, Schwartz Jeffrey Lawrence is listed as Director, 10% Owner at KESTRA MEDICAL TECHNOLOGIES, LTD. Inside the rolling window, Schwartz Jeffrey Lawrence reported no open-market purchases and 1 open-market sale totaling $98K in KMTS.

Companies traded

Other insiders at KMTS

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$98K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
KMTS
Schwartz Jeffrey Lawrence
Sale$98KSep 11SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Schwartz Jeffrey Lawrence made?

Schwartz Jeffrey Lawrence has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.

Which companies does Schwartz Jeffrey Lawrence trade?

Schwartz Jeffrey Lawrence has filed SEC Form 4 disclosures for 1 company, including KMTS.

When was Schwartz Jeffrey Lawrence's most recent SEC Form 4 filing?

Schwartz Jeffrey Lawrence's most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.

What is Schwartz Jeffrey Lawrence's total buy and sell value in the current window?

Inside the rolling retention window, Schwartz Jeffrey Lawrence bought $0 and sold $98K based on SEC Form 4 filings.

What was Schwartz Jeffrey Lawrence's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 3,890 KMTS shares on 2026-09-08, worth $98K, per SEC Form 4 filings.